Adjuvanted Covid-19 vaccine elicits stronger immune response
Drug Discovery World
NOVEMBER 10, 2023
Researchers from Korea conducted a clinical trial to assess the immunogenicity and safety of GBP510/AS03 relative to the ChAdOx1-S vaccine. The researchers found that the immune response induced by two doses of GBP510/AS03 was superior to that induced by ChAdOx1-S.
Let's personalize your content